Mannkind (MNKD) Payables (2010 - 2026)
Mannkind (MNKD) reported Payables of $16.1 million for Q1 2026, down 60.77% year-over-year from $41.1 million in Q1 2025, and down 64.37% quarter-over-quarter from $45.3 million in Q4 2025.
Mannkind (MNKD) Payables (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Payables data on file, last reported at $16.1 million in Q1 2026.
- Payables for Q1 2026 came in at $16.1 million, down 60.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.1 million (down 60.77% YoY), and the FY2025 annual result was $45.3 million, up 567.17% from the prior year.
- Payables slipped to $16.1 million in Q1 2026 per MNKD's latest filing, from $45.3 million in the prior quarter.
- Over five years, Payables peaked at $46.4 million in Q2 2025 and troughed at $6.4 million in Q3 2024.
- A 5-year average of $18.7 million and a median of $11.1 million in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables slumped 61.54% in 2024, then jumped 574.94% in 2025.
- A 5-year view of Payables shows it stood at $11.1 million in 2022, then retreated by 13.32% to $9.6 million in 2023, then retreated by 29.1% to $6.8 million in 2024, then jumped by 567.17% to $45.3 million in 2025, then slumped by 64.37% to $16.1 million in 2026.
- Business Quant data shows MNKD's Payables at $16.1 million in Q1 2026, $45.3 million in Q4 2025, and $43.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.14 Mn |
| Dec 31, 2025 | 45.31 Mn |
| Sep 30, 2025 | 43.49 Mn |
| Jun 30, 2025 | 46.42 Mn |
| Mar 31, 2025 | 41.15 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 9.56 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Dec 31, 2023 | 9.58 Mn |
| Sep 30, 2023 | 16.75 Mn |
| Jun 30, 2023 | 17.13 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 9.87 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 9.53 Mn |
| Jun 30, 2021 | 7.49 Mn |